UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Assessing Patient Perceptions of Goals of Treatment After Consent for Palliative Radiation Therapy

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S197-S197

2016

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S84-S84

2013

Volltextzugriff (PDF)

Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S33-S34

2016

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Intermediate-Risk Prostate Cancer: Five-Year Outcomes From a Multi-institutional Study

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S199-S199

2015

Volltextzugriff (PDF)

Quality of Life Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With 5-Fraction Stereotactic Body Radiation Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E249-E249

2015

Volltextzugriff (PDF)

Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E230-E231

2016

Volltextzugriff (PDF)

Impact of Rectal Bleeding on Quality of Life Measures After Prostate Radiation Therapy: Comparison of the EPIC-26 and EPIC-CP Instruments

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S201-S201

2015

Volltextzugriff (PDF)

Response of Extracranial Lesions After Treatment of Metastatic Melanoma With Cranial Radiation and Ipilimumab

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S775-S775

2014

Volltextzugriff (PDF)

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.2-2

2016

Volltextzugriff (PDF)

Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S84-S85

2014

Volltextzugriff (PDF)

Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S409-S409

2014

Volltextzugriff (PDF)

Transient Radiographic Pseudoprogression Following Fractionated SBRT for Primary Renal Cell Carcinoma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e362-e363

2023

Volltextzugriff (PDF)

Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (3), p.S191-S191

2010

Volltextzugriff (PDF)

Physician Bias, Referral to a Medical Oncologist, and Active Surveillance in Low-risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S182-S182

2012

Volltextzugriff (PDF)

Melanoma Brain Metastases Treated With Brain-directed Radiation Followed by Ipilimumab

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S287-S287

2012

Volltextzugriff (PDF)

Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e511-e511

2024

Volltextzugriff (PDF)

Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB)

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e102-e102

2024

Volltextzugriff (PDF)

Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e370-e370

2024

Volltextzugriff (PDF)

10 Year Prostate Stereotactic Body Radiotherapy Outcomes: Relapse-free Survival, PSA Kinetics And Toxicity From A Pooled Analysis Of Two Multi-Institutional Trials

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e857-e858

2020

Volltextzugriff (PDF)

Referral to a Multidisciplinary Genitourinary Oncology Clinic Increases Rates of Active Surveillance in Low-risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S101-S102

2011

Volltextzugriff (PDF)

Hypofractionated Stereotactic Body Radiotherapy in Low Risk Prostate Adenocarcinoma: Preliminary Results of a Multi-Institutional Phase I Feasibility Trial

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S417-S417

2011

Volltextzugriff (PDF)

Use of a Blood-patch Technique to Reduce Rectal Dose during Cesium-131 Prostate Brachytherapy

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S331-S332

2008

Volltextzugriff (PDF)

A Deep Learning Approach to Radioactive Seed Detection for Prostate Seed Implants

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E794-E794

2019

Volltextzugriff (PDF)

Enzalutamide Monotherapy with EBRT for Intermediate Risk Prostate Cancer. A Phase 2 Study

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E285-E286

2019

Volltextzugriff (PDF)

Risk Factors Predicting Relapse 10 Years Following Extreme Dose-Escalated SBRT for Intermediate-Risk Prostate Cancer: Is De-Intensification Feasible in Unfavorable Subgroups?

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e416-e417

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Radiology
(20)
Hematology, Oncology And Palliative Medicine
(18)
Science & Technology
(9)
Humans
(8)
Life Sciences & Biomedicine
(8)
Male
(8)
Aged
(5)
Middle Aged
(5)
Oncology
(5)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Radiology, Nuclear Medicine & Medical Imaging
(4)
Adult
(3)
Female
(3)
Patients
(3)
Prostate
(3)
Prostatic Neoplasms - Radiotherapy
(3)
Radiotherapy Dosage
(3)
560151 - Radiation Effects On Animals- Man
(2)
Biological Effects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(49)
Elsevier ScienceDirect Journals Collection
(49)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(48)
IngentaConnect Journals
(18)
MEDLINE
(8)
Free E-Journal (出版社公開部分のみ）
(5)
Journals@Ovid Full Text
(5)
Publisher website
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Assessing Patient Perceptions of Goals of Treatment After Consent for Palliative Radiation Therapy

A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma

Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

Stereotactic Body Radiation Therapy for Intermediate-Risk Prostate Cancer: Five-Year Outcomes From a Multi-institutional Study

Quality of Life Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With 5-Fraction Stereotactic Body Radiation Therapy

Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning

Impact of Rectal Bleeding on Quality of Life Measures After Prostate Radiation Therapy: Comparison of the EPIC-26 and EPIC-CP Instruments

Response of Extracranial Lesions After Treatment of Metastatic Melanoma With Cranial Radiation and Ipilimumab

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer

Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment

Transient Radiographic Pseudoprogression Following Fractionated SBRT for Primary Renal Cell Carcinoma

Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors

Physician Bias, Referral to a Medical Oncologist, and Active Surveillance in Low-risk Prostate Cancer

Melanoma Brain Metastases Treated With Brain-directed Radiation Followed by Ipilimumab

Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost

Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB)

Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost

10 Year Prostate Stereotactic Body Radiotherapy Outcomes: Relapse-free Survival, PSA Kinetics And Toxicity From A Pooled Analysis Of Two Multi-Institutional Trials

Referral to a Multidisciplinary Genitourinary Oncology Clinic Increases Rates of Active Surveillance in Low-risk Prostate Cancer

Hypofractionated Stereotactic Body Radiotherapy in Low Risk Prostate Adenocarcinoma: Preliminary Results of a Multi-Institutional Phase I Feasibility Trial

Use of a Blood-patch Technique to Reduce Rectal Dose during Cesium-131 Prostate Brachytherapy

A Deep Learning Approach to Radioactive Seed Detection for Prostate Seed Implants

Enzalutamide Monotherapy with EBRT for Intermediate Risk Prostate Cancer. A Phase 2 Study

Risk Factors Predicting Relapse 10 Years Following Extreme Dose-Escalated SBRT for Intermediate-Risk Prostate Cancer: Is De-Intensification Feasible in Unfavorable Subgroups?

Suchergebnisse filtern